Generics regulatory convergence project extended to more drugs
This article was originally published in SRA
Executive Summary
The European Medicines Agency is to begin sharing its assessment reports on generic medicines with selected non-EU regulatory agencies as part of a drive to improve the efficiency of review processes and make it possible to synchronize marketing authorizations across different jurisdictions1,2.
You may also be interested in...
Two Regulators-Only Groups Agree To Maximize Synergies Under Single Entity
Two groups comprising regulators from around the world – the International Pharmaceutical Regulators Forum and the International Generic Drug Regulators Programme – are to join forces and form a single entity next year.
Two Regulators-Only Groups Agree To Maximize Synergies Under Single Entity
Two groups comprising regulators from around the world – the International Pharmaceutical Regulators Forum and the International Generic Drug Regulators Programme – are to join forces and form a single entity next year.
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.